{"entity":{"type":"insider","cik":"0001886431","url":"/insider/0001886431","json_url":"/insider/0001886431.json","name":"Fitzgerald Kevin Joseph","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":152,"n_filings":13,"first":"2024-06-26","last":"2026-03-06","span_basis":"filed_date"},"name_variants":[{"name":"Fitzgerald Kevin Joseph","source":"filing","n_filings":13,"first_seen":"2024-06-26","last_seen":"2026-03-06"}],"transactions":[{"id":6003996,"accession":"0001735276-26-000059","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001735276-26-000059","line_url":"/filing/0001735276-26-000059#line-12","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":233.0,"shares_display":"233","price_per_share":323.25,"price_display":"323.25","price_state":"stated","total_value":75317.25,"total_display":"75,317.25","shares_owned_after":20870.0,"shares_owned_after_display":"20,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-06","scope":"insider"},{"id":6003993,"accession":"0001735276-26-000059","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001735276-26-000059","line_url":"/filing/0001735276-26-000059#line-11","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":153.0,"shares_display":"153","price_per_share":326.24,"price_display":"326.24","price_state":"stated","total_value":49914.72,"total_display":"49,914.72","shares_owned_after":20569.0,"shares_owned_after_display":"20,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-06","scope":"insider"},{"id":6003990,"accession":"0001735276-26-000059","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001735276-26-000059","line_url":"/filing/0001735276-26-000059#line-10","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":148.0,"shares_display":"148","price_per_share":324.6,"price_display":"324.60","price_state":"stated","total_value":48040.8,"total_display":"48,040.80","shares_owned_after":20722.0,"shares_owned_after_display":"20,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-06","scope":"insider"},{"id":6003987,"accession":"0001735276-26-000059","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001735276-26-000059","line_url":"/filing/0001735276-26-000059#line-9","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":124.0,"shares_display":"124","price_per_share":321.81,"price_display":"321.81","price_state":"stated","total_value":39904.44,"total_display":"39,904.44","shares_owned_after":21103.0,"shares_owned_after_display":"21,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-06","scope":"insider"},{"id":6003985,"accession":"0001735276-26-000059","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001735276-26-000059","line_url":"/filing/0001735276-26-000059#line-8","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":210.0,"shares_display":"210","price_per_share":323.84,"price_display":"323.84","price_state":"stated","total_value":68006.4,"total_display":"68,006.40","shares_owned_after":21359.0,"shares_owned_after_display":"21,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":6003982,"accession":"0001735276-26-000059","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001735276-26-000059","line_url":"/filing/0001735276-26-000059#line-7","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":96.0,"shares_display":"96","price_per_share":323.01,"price_display":"323.01","price_state":"stated","total_value":31008.96,"total_display":"31,008.96","shares_owned_after":21569.0,"shares_owned_after_display":"21,569","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":6003980,"accession":"0001735276-26-000059","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001735276-26-000059","line_url":"/filing/0001735276-26-000059#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79.0,"shares_display":"79","price_per_share":321.82,"price_display":"321.82","price_state":"stated","total_value":25423.78,"total_display":"25,423.78","shares_owned_after":21665.0,"shares_owned_after_display":"21,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":6003977,"accession":"0001735276-26-000059","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-26-000059","line_url":"/filing/0001735276-26-000059#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75.0,"shares_display":"75","price_per_share":324.88,"price_display":"324.88","price_state":"stated","total_value":24366.0,"total_display":"24,366.00","shares_owned_after":21284.0,"shares_owned_after_display":"21,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":6003974,"accession":"0001735276-26-000059","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001735276-26-000059","line_url":"/filing/0001735276-26-000059#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59.0,"shares_display":"59","price_per_share":320.81,"price_display":"320.81","price_state":"stated","total_value":18927.79,"total_display":"18,927.79","shares_owned_after":21744.0,"shares_owned_after_display":"21,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":6003972,"accession":"0001735276-26-000059","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001735276-26-000059","line_url":"/filing/0001735276-26-000059#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":57.0,"shares_display":"57","price_per_share":325.67,"price_display":"325.67","price_state":"stated","total_value":18563.19,"total_display":"18,563.19","shares_owned_after":21227.0,"shares_owned_after_display":"21,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":6003969,"accession":"0001735276-26-000059","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-26-000059","line_url":"/filing/0001735276-26-000059#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29.0,"shares_display":"29","price_per_share":319.03,"price_display":"319.03","price_state":"stated","total_value":9251.87,"total_display":"9,251.87","shares_owned_after":21831.0,"shares_owned_after_display":"21,831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":6003966,"accession":"0001735276-26-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001735276-26-000059","line_url":"/filing/0001735276-26-000059#line-1","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28.0,"shares_display":"28","price_per_share":320.01,"price_display":"320.01","price_state":"stated","total_value":8960.28,"total_display":"8,960.28","shares_owned_after":21803.0,"shares_owned_after_display":"21,803","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":6098826,"accession":"0001735276-26-000051","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001735276-26-000051","line_url":"/filing/0001735276-26-000051#line-15","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":722.0,"shares_display":"722","price_per_share":320.51,"price_display":"320.51","price_state":"stated","total_value":231408.22,"total_display":"231,408.22","shares_owned_after":22219.0,"shares_owned_after_display":"22,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-04","scope":"insider"},{"id":6098824,"accession":"0001735276-26-000051","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001735276-26-000051","line_url":"/filing/0001735276-26-000051#line-14","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":359.0,"shares_display":"359","price_per_share":321.58,"price_display":"321.58","price_state":"stated","total_value":115447.22,"total_display":"115,447.22","shares_owned_after":21860.0,"shares_owned_after_display":"21,860","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-04","scope":"insider"},{"id":6098821,"accession":"0001735276-26-000051","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001735276-26-000051","line_url":"/filing/0001735276-26-000051#line-13","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":289.0,"shares_display":"289","price_per_share":316.55,"price_display":"316.55","price_state":"stated","total_value":91482.95,"total_display":"91,482.95","shares_owned_after":23223.0,"shares_owned_after_display":"23,223","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-04","scope":"insider"},{"id":6098819,"accession":"0001735276-26-000051","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001735276-26-000051","line_url":"/filing/0001735276-26-000051#line-12","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":282.0,"shares_display":"282","price_per_share":318.62,"price_display":"318.62","price_state":"stated","total_value":89850.84,"total_display":"89,850.84","shares_owned_after":22941.0,"shares_owned_after_display":"22,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-04","scope":"insider"},{"id":6098816,"accession":"0001735276-26-000051","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001735276-26-000051","line_url":"/filing/0001735276-26-000051#line-11","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":392.0,"shares_display":"392","price_per_share":326.81,"price_display":"326.81","price_state":"stated","total_value":128109.52,"total_display":"128,109.52","shares_owned_after":24323.0,"shares_owned_after_display":"24,323","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":6098814,"accession":"0001735276-26-000051","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001735276-26-000051","line_url":"/filing/0001735276-26-000051#line-10","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":329.0,"shares_display":"329","price_per_share":327.67,"price_display":"327.67","price_state":"stated","total_value":107803.43,"total_display":"107,803.43","shares_owned_after":23994.0,"shares_owned_after_display":"23,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":6098811,"accession":"0001735276-26-000051","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001735276-26-000051","line_url":"/filing/0001735276-26-000051#line-9","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":258.0,"shares_display":"258","price_per_share":325.63,"price_display":"325.63","price_state":"stated","total_value":84012.54,"total_display":"84,012.54","shares_owned_after":24715.0,"shares_owned_after_display":"24,715","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":6098809,"accession":"0001735276-26-000051","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001735276-26-000051","line_url":"/filing/0001735276-26-000051#line-8","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":170.0,"shares_display":"170","price_per_share":329.71,"price_display":"329.71","price_state":"stated","total_value":56050.7,"total_display":"56,050.70","shares_owned_after":23724.0,"shares_owned_after_display":"23,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":6098807,"accession":"0001735276-26-000051","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001735276-26-000051","line_url":"/filing/0001735276-26-000051#line-7","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":328.71,"price_display":"328.71","price_state":"stated","total_value":32871.0,"total_display":"32,871.00","shares_owned_after":23894.0,"shares_owned_after_display":"23,894","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":6098804,"accession":"0001735276-26-000051","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001735276-26-000051","line_url":"/filing/0001735276-26-000051#line-6","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94.0,"shares_display":"94","price_per_share":331.93,"price_display":"331.93","price_state":"stated","total_value":31201.42,"total_display":"31,201.42","shares_owned_after":23549.0,"shares_owned_after_display":"23,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":6098801,"accession":"0001735276-26-000051","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001735276-26-000051","line_url":"/filing/0001735276-26-000051#line-5","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90.0,"shares_display":"90","price_per_share":324.65,"price_display":"324.65","price_state":"stated","total_value":29218.5,"total_display":"29,218.50","shares_owned_after":24973.0,"shares_owned_after_display":"24,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":6098797,"accession":"0001735276-26-000051","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001735276-26-000051","line_url":"/filing/0001735276-26-000051#line-4","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":81.0,"shares_display":"81","price_per_share":330.85,"price_display":"330.85","price_state":"stated","total_value":26798.85,"total_display":"26,798.85","shares_owned_after":23643.0,"shares_owned_after_display":"23,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":6098793,"accession":"0001735276-26-000051","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001735276-26-000051","line_url":"/filing/0001735276-26-000051#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47.0,"shares_display":"47","price_per_share":323.62,"price_display":"323.62","price_state":"stated","total_value":15210.14,"total_display":"15,210.14","shares_owned_after":25063.0,"shares_owned_after_display":"25,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":6098790,"accession":"0001735276-26-000051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-26-000051","line_url":"/filing/0001735276-26-000051#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37.0,"shares_display":"37","price_per_share":332.64,"price_display":"332.64","price_state":"stated","total_value":12307.68,"total_display":"12,307.68","shares_owned_after":23512.0,"shares_owned_after_display":"23,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5988434,"accession":"0001735276-26-000026","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001735276-26-000026","line_url":"/filing/0001735276-26-000026#line-3","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2041.0,"shares_display":"2,041","price_per_share":331.9606,"price_display":"331.96","price_state":"stated","total_value":677531.5846,"total_display":"677,531.58","shares_owned_after":21264.0,"shares_owned_after_display":"21,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-17","scope":"insider"},{"id":5988430,"accession":"0001735276-26-000026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001735276-26-000026","line_url":"/filing/0001735276-26-000026#line-2","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1959.0,"shares_display":"1,959","price_per_share":310.0808,"price_display":"310.08","price_state":"stated","total_value":607448.2872,"total_display":"607,448.29","shares_owned_after":23305.0,"shares_owned_after_display":"23,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-13","filed_date":"2026-02-17","scope":"insider"},{"id":6115041,"accession":"0001735276-26-000011","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-28","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":644.0,"shares_display":"644","price_per_share":370.0,"price_display":"370.00","price_state":"stated","total_value":238280.0,"total_display":"238,280.00","shares_owned_after":22151.0,"shares_owned_after_display":"22,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-14","scope":"insider"},{"id":6115038,"accession":"0001735276-26-000011","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-27","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":562.0,"shares_display":"562","price_per_share":368.76,"price_display":"368.76","price_state":"stated","total_value":207243.12,"total_display":"207,243.12","shares_owned_after":22795.0,"shares_owned_after_display":"22,795","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-14","scope":"insider"},{"id":6115035,"accession":"0001735276-26-000011","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-26","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":485.0,"shares_display":"485","price_per_share":371.24,"price_display":"371.24","price_state":"stated","total_value":180051.4,"total_display":"180,051.40","shares_owned_after":21666.0,"shares_owned_after_display":"21,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-14","scope":"insider"},{"id":6115033,"accession":"0001735276-26-000011","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-25","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":280.0,"shares_display":"280","price_per_share":372.93,"price_display":"372.93","price_state":"stated","total_value":104420.4,"total_display":"104,420.40","shares_owned_after":21386.0,"shares_owned_after_display":"21,386","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-14","scope":"insider"},{"id":6115031,"accession":"0001735276-26-000011","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-24","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":197.0,"shares_display":"197","price_per_share":367.52,"price_display":"367.52","price_state":"stated","total_value":72401.44,"total_display":"72,401.44","shares_owned_after":23357.0,"shares_owned_after_display":"23,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-14","scope":"insider"},{"id":6115027,"accession":"0001735276-26-000011","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-23","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":122.0,"shares_display":"122","price_per_share":374.33,"price_display":"374.33","price_state":"stated","total_value":45668.26,"total_display":"45,668.26","shares_owned_after":21264.0,"shares_owned_after_display":"21,264","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-13","filed_date":"2026-01-14","scope":"insider"},{"id":6115025,"accession":"0001735276-26-000011","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-22","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":220.0,"shares_display":"220","price_per_share":365.56,"price_display":"365.56","price_state":"stated","total_value":80423.2,"total_display":"80,423.20","shares_owned_after":23846.0,"shares_owned_after_display":"23,846","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6115021,"accession":"0001735276-26-000011","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-21","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":199.0,"shares_display":"199","price_per_share":364.83,"price_display":"364.83","price_state":"stated","total_value":72601.17,"total_display":"72,601.17","shares_owned_after":24066.0,"shares_owned_after_display":"24,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6115015,"accession":"0001735276-26-000011","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-20","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155.0,"shares_display":"155","price_per_share":360.22,"price_display":"360.22","price_state":"stated","total_value":55834.1,"total_display":"55,834.10","shares_owned_after":24483.0,"shares_owned_after_display":"24,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6115012,"accession":"0001735276-26-000011","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-19","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":123.0,"shares_display":"123","price_per_share":358.18,"price_display":"358.18","price_state":"stated","total_value":44056.14,"total_display":"44,056.14","shares_owned_after":24723.0,"shares_owned_after_display":"24,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6115009,"accession":"0001735276-26-000011","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-18","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":98.0,"shares_display":"98","price_per_share":361.45,"price_display":"361.45","price_state":"stated","total_value":35422.1,"total_display":"35,422.10","shares_owned_after":24385.0,"shares_owned_after_display":"24,385","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6115007,"accession":"0001735276-26-000011","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-17","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":96.0,"shares_display":"96","price_per_share":357.17,"price_display":"357.17","price_state":"stated","total_value":34288.32,"total_display":"34,288.32","shares_owned_after":24846.0,"shares_owned_after_display":"24,846","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6115004,"accession":"0001735276-26-000011","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-16","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92.0,"shares_display":"92","price_per_share":368.62,"price_display":"368.62","price_state":"stated","total_value":33913.04,"total_display":"33,913.04","shares_owned_after":23663.0,"shares_owned_after_display":"23,663","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6115001,"accession":"0001735276-26-000011","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-15","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85.0,"shares_display":"85","price_per_share":359.14,"price_display":"359.14","price_state":"stated","total_value":30526.9,"total_display":"30,526.90","shares_owned_after":24638.0,"shares_owned_after_display":"24,638","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6114999,"accession":"0001735276-26-000011","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-14","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73.0,"shares_display":"73","price_per_share":362.38,"price_display":"362.38","price_state":"stated","total_value":26453.74,"total_display":"26,453.74","shares_owned_after":24312.0,"shares_owned_after_display":"24,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6114996,"accession":"0001735276-26-000011","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-13","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50.0,"shares_display":"50","price_per_share":366.41,"price_display":"366.41","price_state":"stated","total_value":18320.5,"total_display":"18,320.50","shares_owned_after":23796.0,"shares_owned_after_display":"23,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6114993,"accession":"0001735276-26-000011","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-12","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47.0,"shares_display":"47","price_per_share":363.55,"price_display":"363.55","price_state":"stated","total_value":17086.85,"total_display":"17,086.85","shares_owned_after":24265.0,"shares_owned_after_display":"24,265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6114990,"accession":"0001735276-26-000011","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-11","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42.0,"shares_display":"42","price_per_share":355.16,"price_display":"355.16","price_state":"stated","total_value":14916.72,"total_display":"14,916.72","shares_owned_after":24983.0,"shares_owned_after_display":"24,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6114988,"accession":"0001735276-26-000011","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-10","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41.0,"shares_display":"41","price_per_share":367.4,"price_display":"367.40","price_state":"stated","total_value":15063.4,"total_display":"15,063.40","shares_owned_after":23755.0,"shares_owned_after_display":"23,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6114985,"accession":"0001735276-26-000011","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-9","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41.0,"shares_display":"41","price_per_share":356.09,"price_display":"356.09","price_state":"stated","total_value":14599.69,"total_display":"14,599.69","shares_owned_after":24942.0,"shares_owned_after_display":"24,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6114982,"accession":"0001735276-26-000011","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-8","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40.0,"shares_display":"40","price_per_share":369.48,"price_display":"369.48","price_state":"stated","total_value":14779.2,"total_display":"14,779.20","shares_owned_after":23623.0,"shares_owned_after_display":"23,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"},{"id":6114979,"accession":"0001735276-26-000011","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001735276-26-000011","line_url":"/filing/0001735276-26-000011#line-7","is_derivative":false,"issuer_cik":"0001178670","issuer_name":"ALNYLAM PHARMACEUTICALS, INC.","issuer_ticker":"ALNY","issuer_name_source":null,"issuer_url":"/issuer/0001178670","owner_cik":"0001886431","owner_name":"Fitzgerald Kevin Joseph","owner_url":"/insider/0001886431","role":"Officer (CSO & EVP, Head of Research)","officer_title":"CSO & EVP, Head of Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39.0,"shares_display":"39","price_per_share":353.95,"price_display":"353.95","price_state":"stated","total_value":13804.05,"total_display":"13,804.05","shares_owned_after":25025.0,"shares_owned_after_display":"25,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-12","filed_date":"2026-01-14","scope":"insider"}],"next_cursor":"2026-01-12|6114979","ledger_fault":false,"count":{"value":152,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":152,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":152},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001178670","name":"ALNYLAM PHARMACEUTICALS, INC.","url":"/issuer/0001178670","role":"Officer (CSO & EVP, Head of Research)","n_filings":13,"first_seen":"2024-06-26","last_seen":"2026-03-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001886431","retrieved_at":"2026-08-21T04:33:17+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}